Skip to main navigation Skip to search Skip to main content

Traumatic brain injury and RSI is rocuronium or succinylcholine preferred?

Research output: Contribution to journalReview articlepeer-review

Abstract

Purpose of reviewTraumatic brain injury is widespread and has significant morbidity and mortality. Patients with severe traumatic brain injury often necessitate intubation. The paralytic for rapid sequence induction and intubation for the patient with traumatic brain injury has not been standardized.Recent findingsRapid sequence induction is the standard of care for patients with traumatic brain injury. Historically, succinylcholine has been the agent of choice due to its fast onset and short duration of action, but it has numerous adverse effects such as increased intracranial pressure and hyperkalemia. Rocuronium, when dosed appropriately, provides neuromuscular blockade as quickly and effectively as succinylcholine but was previously avoided due to its prolonged duration of action which precluded neurologic examination. However, with the widespread availability of sugammadex, rocuronium is able to be reversed in a timely manner.SummaryIn patients with traumatic brain injury necessitating intubation, rocuronium appears to be safer than succinylcholine.

Original languageEnglish (US)
Pages (from-to)163-167
Number of pages5
JournalCurrent opinion in anaesthesiology
Volume36
Issue number2
DOIs
StatePublished - Apr 1 2023

Keywords

  • rapid sequence induction
  • rocuronium
  • succinylcholine
  • sugammadex
  • traumatic brain injury

ASJC Scopus subject areas

  • Anesthesiology and Pain Medicine

Fingerprint

Dive into the research topics of 'Traumatic brain injury and RSI is rocuronium or succinylcholine preferred?'. Together they form a unique fingerprint.

Cite this